| 0 |
HETEROGENEOUS TESTIS |
1 |
0.5000 |
| 1 |
BLEEDING TIME |
1 |
0.1429 |
| 2 |
PREALBUMIN INCREASED |
1 |
0.0455 |
| 3 |
ACQUIRED ATTR AMYLOIDOSIS |
1 |
0.0244 |
| 4 |
VENTRICULAR INTERNAL DIAMETER ABNORMAL |
1 |
0.0105 |
| 5 |
PREALBUMIN DECREASED |
1 |
0.0083 |
| 6 |
PANCREATIC ABSCESS |
1 |
0.0050 |
| 7 |
ECG SIGNS OF MYOCARDIAL ISCHAEMIA |
1 |
0.0044 |
| 8 |
ENVIRONMENTAL EXPOSURE |
1 |
0.0042 |
| 9 |
BETA 2 MICROGLOBULIN INCREASED |
1 |
0.0038 |
| 10 |
HEART FAILURE WITH PRESERVED EJECTION FRACTION |
1 |
0.0034 |
| 11 |
PNEUMONITIS ASPIRATION |
1 |
0.0029 |
| 12 |
PRODUCT PACKAGING DIFFICULT TO OPEN |
7 |
0.0027 |
| 13 |
INCORRECT PRODUCT DOSAGE FORM ADMINISTERED |
1 |
0.0024 |
| 14 |
URGE INCONTINENCE |
2 |
0.0023 |
| 15 |
IMMUNOGLOBULINS INCREASED |
1 |
0.0021 |
| 16 |
BLOOD CREATINE ABNORMAL |
1 |
0.0021 |
| 17 |
AUTONOMIC NEUROPATHY |
2 |
0.0020 |
| 18 |
HEAT ILLNESS |
1 |
0.0015 |
| 19 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
7 |
0.0014 |
| 20 |
HEART SOUNDS ABNORMAL |
1 |
0.0013 |
| 21 |
VASOCONSTRICTION |
1 |
0.0011 |
| 22 |
INTUSSUSCEPTION |
1 |
0.0010 |
| 23 |
LIGHT CHAIN ANALYSIS INCREASED |
1 |
0.0010 |
| 24 |
PRODUCT BLISTER PACKAGING ISSUE |
1 |
0.0010 |
| 25 |
BLOOD SODIUM ABNORMAL |
1 |
0.0009 |
| 26 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 27 |
RECTAL TENESMUS |
1 |
0.0008 |
| 28 |
PROTEIN TOTAL ABNORMAL |
1 |
0.0008 |
| 29 |
IMPLANTABLE DEFIBRILLATOR INSERTION |
1 |
0.0008 |
| 30 |
PRODUCT SIZE ISSUE |
4 |
0.0007 |
| 31 |
GLOMERULAR FILTRATION RATE ABNORMAL |
1 |
0.0007 |
| 32 |
GENITAL RASH |
1 |
0.0007 |
| 33 |
MEDICAL DEVICE IMPLANTATION |
1 |
0.0006 |
| 34 |
LEFT VENTRICULAR FAILURE |
2 |
0.0006 |
| 35 |
AMYLOIDOSIS |
1 |
0.0006 |
| 36 |
GLOMERULAR FILTRATION RATE DECREASED |
7 |
0.0006 |
| 37 |
PRODUCT STORAGE ISSUE |
2 |
0.0005 |
| 38 |
PANCREATIC CYST |
1 |
0.0005 |
| 39 |
SPINAL STENOSIS |
2 |
0.0005 |
| 40 |
ATRIAL THROMBOSIS |
1 |
0.0005 |
| 41 |
WALKING DISABILITY |
1 |
0.0005 |
| 42 |
BLOOD PRESSURE SYSTOLIC DECREASED |
2 |
0.0004 |
| 43 |
MENOPAUSAL SYMPTOMS |
1 |
0.0004 |
| 44 |
RETINAL ARTERY OCCLUSION |
1 |
0.0004 |
| 45 |
BLOOD POTASSIUM ABNORMAL |
1 |
0.0004 |
| 46 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 47 |
BLOOD PARATHYROID HORMONE INCREASED |
1 |
0.0003 |
| 48 |
BRADYKINESIA |
2 |
0.0003 |
| 49 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
1 |
0.0003 |
| 50 |
BLOOD CREATININE INCREASED |
21 |
0.0003 |
| 51 |
FOREIGN BODY IN THROAT |
1 |
0.0003 |
| 52 |
NON-CARDIAC CHEST PAIN |
1 |
0.0003 |
| 53 |
PRODUCT PACKAGING ISSUE |
3 |
0.0003 |
| 54 |
CARDIAC FAILURE ACUTE |
2 |
0.0003 |
| 55 |
LYME DISEASE |
1 |
0.0003 |
| 56 |
DEPRESSIVE SYMPTOM |
1 |
0.0003 |
| 57 |
PRODUCT SUPPLY ISSUE |
2 |
0.0003 |
| 58 |
CAROTID ARTERY OCCLUSION |
1 |
0.0003 |
| 59 |
FEELING DRUNK |
2 |
0.0003 |
| 60 |
CONJUNCTIVAL HAEMORRHAGE |
1 |
0.0003 |
| 61 |
EPIGASTRIC DISCOMFORT |
1 |
0.0003 |
| 62 |
SKIN ODOUR ABNORMAL |
1 |
0.0003 |
| 63 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 64 |
SLEEP TERROR |
1 |
0.0002 |
| 65 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 66 |
URINE ABNORMALITY |
1 |
0.0002 |
| 67 |
COLITIS MICROSCOPIC |
1 |
0.0002 |
| 68 |
PROTEIN URINE PRESENT |
1 |
0.0002 |
| 69 |
FLUID INTAKE REDUCED |
1 |
0.0002 |
| 70 |
TOXIC ENCEPHALOPATHY |
1 |
0.0002 |
| 71 |
FAILURE TO THRIVE |
1 |
0.0002 |
| 72 |
EXERCISE TOLERANCE DECREASED |
1 |
0.0002 |
| 73 |
ORTHOSTATIC HYPOTENSION |
3 |
0.0002 |
| 74 |
STRESS CARDIOMYOPATHY |
1 |
0.0002 |
| 75 |
PRODUCT LABEL CONFUSION |
1 |
0.0002 |
| 76 |
PRE-EXISTING CONDITION IMPROVED |
1 |
0.0002 |
| 77 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 78 |
PRODUCT LABEL ISSUE |
1 |
0.0001 |
| 79 |
LARGE INTESTINE POLYP |
1 |
0.0001 |
| 80 |
INTERNATIONAL NORMALISED RATIO INCREASED |
4 |
0.0001 |
| 81 |
FAECES SOFT |
1 |
0.0001 |
| 82 |
RASH PUSTULAR |
1 |
0.0001 |
| 83 |
APATHY |
2 |
0.0001 |
| 84 |
INSURANCE ISSUE |
2 |
0.0001 |
| 85 |
THYROID DISORDER |
2 |
0.0001 |
| 86 |
APNOEA |
1 |
0.0001 |
| 87 |
BRAIN FOG |
2 |
0.0001 |
| 88 |
PRODUCT USE COMPLAINT |
2 |
0.0001 |
| 89 |
TRICUSPID VALVE INCOMPETENCE |
1 |
0.0001 |
| 90 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 91 |
RHINITIS |
1 |
0.0001 |
| 92 |
THERAPY CESSATION |
6 |
0.0001 |
| 93 |
GROIN PAIN |
1 |
0.0001 |
| 94 |
THERAPEUTIC RESPONSE UNEXPECTED |
5 |
0.0001 |
| 95 |
ANAL INCONTINENCE |
1 |
0.0001 |
| 96 |
OROPHARYNGEAL DISCOMFORT |
1 |
0.0001 |
| 97 |
ABDOMINAL DISCOMFORT |
18 |
0.0001 |
| 98 |
DIARRHOEA |
69 |
0.0001 |
| 99 |
INTENTIONAL DOSE OMISSION |
3 |
0.0001 |
| 100 |
PROTEINURIA |
2 |
0.0001 |
| 101 |
LETHARGY |
6 |
0.0001 |
| 102 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 103 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 104 |
PRODUCT STORAGE ERROR |
9 |
0.0001 |
| 105 |
BLOOD PRESSURE SYSTOLIC INCREASED |
2 |
0.0001 |
| 106 |
DECREASED IMMUNE RESPONSIVENESS |
1 |
0.0001 |
| 107 |
THERAPY CHANGE |
1 |
0.0001 |
| 108 |
HOSPICE CARE |
1 |
0.0001 |
| 109 |
INABILITY TO AFFORD MEDICATION |
1 |
0.0001 |
| 110 |
GASTROINTESTINAL DISORDER |
9 |
0.0001 |
| 111 |
HYPOTHERMIA |
1 |
0.0001 |
| 112 |
TEMPERATURE INTOLERANCE |
1 |
0.0001 |
| 113 |
POOR VENOUS ACCESS |
1 |
0.0001 |
| 114 |
DYSPHAGIA |
9 |
0.0001 |
| 115 |
RETCHING |
2 |
0.0001 |
| 116 |
FAECES DISCOLOURED |
2 |
0.0001 |
| 117 |
BACK INJURY |
1 |
0.0001 |
| 118 |
OESOPHAGITIS |
1 |
0.0001 |
| 119 |
ASPIRATION |
1 |
0.0001 |
| 120 |
LIP SWELLING |
3 |
0.0001 |
| 121 |
NEPHROPATHY TOXIC |
1 |
0.0001 |
| 122 |
MITRAL VALVE INCOMPETENCE |
1 |
0.0001 |
| 123 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 124 |
NEURALGIA |
2 |
0.0001 |
| 125 |
CARDIOMEGALY |
1 |
0.0001 |
| 126 |
SMALL INTESTINAL OBSTRUCTION |
1 |
0.0001 |
| 127 |
CYST |
1 |
0.0001 |
| 128 |
DYSPNOEA EXERTIONAL |
3 |
0.0001 |
| 129 |
ABDOMINAL PAIN LOWER |
2 |
0.0001 |
| 130 |
MUSCLE ATROPHY |
1 |
0.0001 |
| 131 |
PULMONARY CONGESTION |
1 |
0.0001 |
| 132 |
MENTAL STATUS CHANGES |
2 |
0.0001 |
| 133 |
APHONIA |
1 |
0.0001 |
| 134 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 135 |
CARPAL TUNNEL SYNDROME |
1 |
0.0001 |
| 136 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 137 |
PARAESTHESIA ORAL |
1 |
0.0001 |
| 138 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 139 |
COMPLICATION ASSOCIATED WITH DEVICE |
1 |
0.0001 |
| 140 |
GASTROENTERITIS |
1 |
0.0001 |
| 141 |
CARDIOMYOPATHY |
1 |
0.0001 |
| 142 |
DRUG EFFECT LESS THAN EXPECTED |
1 |
0.0001 |
| 143 |
COLON CANCER |
1 |
0.0001 |
| 144 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 145 |
THROAT IRRITATION |
3 |
0.0001 |
| 146 |
MUSCULOSKELETAL CHEST PAIN |
1 |
0.0001 |
| 147 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 148 |
ABDOMINAL PAIN UPPER |
13 |
0.0001 |
| 149 |
SCIATICA |
1 |
0.0001 |
| 150 |
DYSPEPSIA |
6 |
0.0001 |
| 151 |
BLOOD PRESSURE DECREASED |
4 |
0.0001 |
| 152 |
VIRAL INFECTION |
2 |
0.0001 |
| 153 |
CANDIDA INFECTION |
1 |
0.0001 |
| 154 |
WEIGHT DECREASED |
16 |
0.0001 |
| 155 |
CEREBRAL HAEMORRHAGE |
2 |
0.0001 |
| 156 |
GOUT |
1 |
0.0001 |
| 157 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 158 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 159 |
EYE SWELLING |
2 |
0.0001 |
| 160 |
HYPONATRAEMIA |
3 |
0.0001 |
| 161 |
PHOTOPHOBIA |
1 |
0.0001 |
| 162 |
FLATULENCE |
3 |
0.0001 |
| 163 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 164 |
BLOOD URINE PRESENT |
1 |
0.0001 |
| 165 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 166 |
DYSPHONIA |
3 |
0.0001 |
| 167 |
PRODUCT DOSE OMISSION ISSUE |
15 |
0.0001 |
| 168 |
PRESCRIBED UNDERDOSE |
1 |
0.0001 |
| 169 |
GASTROOESOPHAGEAL REFLUX DISEASE |
4 |
0.0000 |
| 170 |
RIB FRACTURE |
1 |
0.0000 |
| 171 |
ABDOMINAL DISTENSION |
5 |
0.0000 |
| 172 |
EATING DISORDER |
1 |
0.0000 |
| 173 |
POOR QUALITY SLEEP |
1 |
0.0000 |
| 174 |
BALANCE DISORDER |
4 |
0.0000 |
| 175 |
DIZZINESS |
23 |
0.0000 |
| 176 |
ACUTE KIDNEY INJURY |
7 |
0.0000 |
| 177 |
RASH MACULO-PAPULAR |
1 |
0.0000 |
| 178 |
PULMONARY OEDEMA |
2 |
0.0000 |
| 179 |
CHROMATURIA |
1 |
0.0000 |
| 180 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 181 |
NEPHROLITHIASIS |
2 |
0.0000 |
| 182 |
SKIN DISCOLOURATION |
2 |
0.0000 |
| 183 |
CARDIAC DISORDER |
4 |
0.0000 |
| 184 |
ARRHYTHMIA |
2 |
0.0000 |
| 185 |
PRODUCTIVE COUGH |
2 |
0.0000 |
| 186 |
BLOOD PRESSURE FLUCTUATION |
1 |
0.0000 |
| 187 |
LOCALISED INFECTION |
1 |
0.0000 |
| 188 |
MENTAL IMPAIRMENT |
1 |
0.0000 |
| 189 |
UNDERDOSE |
3 |
0.0000 |
| 190 |
LIVER INJURY |
1 |
0.0000 |
| 191 |
AGEUSIA |
1 |
0.0000 |
| 192 |
ASTHENIA |
15 |
0.0000 |
| 193 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
8 |
0.0000 |
| 194 |
HYPOPHAGIA |
1 |
0.0000 |
| 195 |
ERECTILE DYSFUNCTION |
1 |
0.0000 |
| 196 |
ILLNESS |
4 |
0.0000 |
| 197 |
CARDIAC FAILURE |
3 |
0.0000 |
| 198 |
FATIGUE |
29 |
0.0000 |
| 199 |
BLOOD BILIRUBIN INCREASED |
1 |
0.0000 |
| 200 |
THROAT TIGHTNESS |
1 |
0.0000 |
| 201 |
HAEMOPTYSIS |
1 |
0.0000 |
| 202 |
DEMENTIA |
1 |
0.0000 |
| 203 |
PRODUCT DOSE OMISSION IN ERROR |
1 |
0.0000 |
| 204 |
SOMNOLENCE |
7 |
0.0000 |
| 205 |
DECREASED APPETITE |
8 |
0.0000 |
| 206 |
ABDOMINAL PAIN |
8 |
0.0000 |
| 207 |
DYSSTASIA |
1 |
0.0000 |
| 208 |
RENAL INJURY |
1 |
0.0000 |
| 209 |
HYPOAESTHESIA |
5 |
0.0000 |
| 210 |
CORONARY ARTERY DISEASE |
1 |
0.0000 |
| 211 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 212 |
FEMUR FRACTURE |
1 |
0.0000 |
| 213 |
CONSTIPATION |
7 |
0.0000 |
| 214 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 215 |
BONE DENSITY DECREASED |
1 |
0.0000 |
| 216 |
GAIT DISTURBANCE |
6 |
0.0000 |
| 217 |
HIP FRACTURE |
1 |
0.0000 |
| 218 |
NIGHT SWEATS |
1 |
0.0000 |
| 219 |
AMNESIA |
2 |
0.0000 |
| 220 |
SWELLING FACE |
2 |
0.0000 |
| 221 |
EYE DISORDER |
1 |
0.0000 |
| 222 |
TREMOR |
5 |
0.0000 |
| 223 |
RENAL FAILURE |
4 |
0.0000 |
| 224 |
DEHYDRATION |
4 |
0.0000 |
| 225 |
SYNCOPE |
3 |
0.0000 |
| 226 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
1 |
0.0000 |
| 227 |
CHEST DISCOMFORT |
3 |
0.0000 |
| 228 |
DELIRIUM |
1 |
0.0000 |
| 229 |
HEART RATE DECREASED |
1 |
0.0000 |
| 230 |
DYSPNOEA |
16 |
0.0000 |
| 231 |
THERAPY INTERRUPTED |
2 |
0.0000 |
| 232 |
DYSURIA |
1 |
0.0000 |
| 233 |
DYSGEUSIA |
2 |
0.0000 |
| 234 |
DYSARTHRIA |
1 |
0.0000 |
| 235 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 236 |
UNEVALUABLE EVENT |
2 |
0.0000 |
| 237 |
MUSCULAR WEAKNESS |
3 |
0.0000 |
| 238 |
COLITIS |
1 |
0.0000 |
| 239 |
HOSPITALISATION |
4 |
0.0000 |
| 240 |
BACK PAIN |
6 |
0.0000 |
| 241 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 242 |
DISORIENTATION |
1 |
0.0000 |
| 243 |
RASH |
11 |
0.0000 |
| 244 |
DRY MOUTH |
2 |
0.0000 |
| 245 |
POLLAKIURIA |
1 |
0.0000 |
| 246 |
ROAD TRAFFIC ACCIDENT |
1 |
0.0000 |
| 247 |
PRURITUS |
9 |
0.0000 |
| 248 |
INTENTIONAL PRODUCT USE ISSUE |
2 |
0.0000 |
| 249 |
NAUSEA |
18 |
0.0000 |
| 250 |
SUICIDAL IDEATION |
2 |
0.0000 |
| 251 |
MUSCLE SPASMS |
4 |
0.0000 |
| 252 |
ADVERSE EVENT |
2 |
0.0000 |
| 253 |
RENAL DISORDER |
1 |
0.0000 |
| 254 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 255 |
PRODUCT USE ISSUE |
4 |
0.0000 |
| 256 |
OCULAR HYPERAEMIA |
1 |
0.0000 |
| 257 |
ANAEMIA |
4 |
0.0000 |
| 258 |
RASH ERYTHEMATOUS |
1 |
0.0000 |
| 259 |
CONTUSION |
2 |
0.0000 |
| 260 |
LEUKOPENIA |
1 |
0.0000 |
| 261 |
AGGRESSION |
1 |
0.0000 |
| 262 |
FLUID RETENTION |
1 |
0.0000 |
| 263 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 264 |
ARTHRALGIA |
8 |
0.0000 |
| 265 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 266 |
PANCREATITIS |
1 |
0.0000 |
| 267 |
DEPRESSED MOOD |
1 |
0.0000 |
| 268 |
DRUG INTERACTION |
3 |
0.0000 |
| 269 |
BRADYCARDIA |
1 |
0.0000 |
| 270 |
DISTURBANCE IN ATTENTION |
1 |
0.0000 |
| 271 |
OEDEMA |
1 |
0.0000 |
| 272 |
MALAISE |
8 |
0.0000 |
| 273 |
FALL |
6 |
0.0000 |
| 274 |
URTICARIA |
3 |
0.0000 |
| 275 |
NECK PAIN |
1 |
0.0000 |
| 276 |
COUGH |
5 |
0.0000 |
| 277 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 278 |
URINARY TRACT INFECTION |
3 |
0.0000 |
| 279 |
PALPITATIONS |
2 |
0.0000 |
| 280 |
CHILLS |
2 |
0.0000 |
| 281 |
SURGERY |
1 |
0.0000 |
| 282 |
NASAL CONGESTION |
1 |
0.0000 |
| 283 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
3 |
0.0000 |
| 284 |
IRRITABILITY |
1 |
0.0000 |
| 285 |
SUICIDE ATTEMPT |
1 |
0.0000 |
| 286 |
STOMATITIS |
1 |
0.0000 |
| 287 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 288 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 289 |
DISCOMFORT |
1 |
0.0000 |
| 290 |
FEELING HOT |
1 |
0.0000 |
| 291 |
CHEST PAIN |
3 |
0.0000 |
| 292 |
RHINORRHOEA |
1 |
0.0000 |
| 293 |
DRY SKIN |
2 |
0.0000 |
| 294 |
HYPOTENSION |
3 |
0.0000 |
| 295 |
VOMITING |
7 |
0.0000 |
| 296 |
BURNING SENSATION |
1 |
0.0000 |
| 297 |
SLEEP DISORDER |
1 |
0.0000 |
| 298 |
HYPERTENSION |
3 |
0.0000 |
| 299 |
ANXIETY |
4 |
0.0000 |
| 300 |
MOBILITY DECREASED |
1 |
0.0000 |
| 301 |
WEIGHT INCREASED |
3 |
0.0000 |
| 302 |
HALLUCINATION |
1 |
0.0000 |
| 303 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 304 |
CONDITION AGGRAVATED |
4 |
0.0000 |
| 305 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 306 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 307 |
CONFUSIONAL STATE |
2 |
0.0000 |
| 308 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 309 |
CEREBROVASCULAR ACCIDENT |
2 |
0.0000 |
| 310 |
INTENTIONAL PRODUCT MISUSE |
1 |
0.0000 |
| 311 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 312 |
INSOMNIA |
3 |
0.0000 |
| 313 |
TACHYCARDIA |
1 |
0.0000 |
| 314 |
DEVICE ISSUE |
1 |
0.0000 |
| 315 |
BLOOD GLUCOSE INCREASED |
2 |
0.0000 |
| 316 |
PULMONARY EMBOLISM |
1 |
0.0000 |
| 317 |
NEUROPATHY PERIPHERAL |
1 |
0.0000 |
| 318 |
DEATH |
9 |
0.0000 |
| 319 |
ALOPECIA |
2 |
0.0000 |
| 320 |
PAIN IN EXTREMITY |
3 |
0.0000 |
| 321 |
ERYTHEMA |
2 |
0.0000 |
| 322 |
WHITE BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 323 |
INFLUENZA |
1 |
0.0000 |
| 324 |
SEPSIS |
1 |
0.0000 |
| 325 |
ASTHMA |
1 |
0.0000 |
| 326 |
JOINT SWELLING |
1 |
0.0000 |
| 327 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 328 |
PAIN |
5 |
0.0000 |
| 329 |
HEADACHE |
5 |
0.0000 |
| 330 |
LOSS OF CONSCIOUSNESS |
1 |
0.0000 |
| 331 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 332 |
PARAESTHESIA |
1 |
0.0000 |
| 333 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 334 |
MYALGIA |
1 |
0.0000 |
| 335 |
MYOCARDIAL INFARCTION |
1 |
0.0000 |
| 336 |
NO ADVERSE EVENT |
1 |
0.0000 |
| 337 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 338 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 339 |
OVERDOSE |
1 |
0.0000 |
| 340 |
DEPRESSION |
1 |
0.0000 |
| 341 |
FEELING ABNORMAL |
1 |
0.0000 |
| 342 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 343 |
INJECTION SITE PAIN |
1 |
0.0000 |
| 344 |
PNEUMONIA |
1 |
0.0000 |
| 345 |
PYREXIA |
1 |
0.0000 |
| 346 |
DRUG INEFFECTIVE |
2 |
0.0000 |
| 347 |
OFF LABEL USE |
1 |
0.0000 |